Search Results - Peter Probst

Peter Probst

Peter Probst in 2011 }}

}}

Peter Probst is a former Swiss slalom canoeist who competed in the 1970s. He won a bronze medal in the C-2 team event at the 1979 ICF Canoe Slalom World Championships in Jonquière. Provided by Wikipedia
  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial. by Eric J Tarcha, Chelsea M Olsen, Peter Probst, David Peckham, Ernesto J Muñoz-Elías, James G Kruger, Shawn P Iadonato

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  2. 2

    271 Development of OR2805, an anti-CD163 antibody derived from an elite responder to checkpoint inhibitor therapy that relieves immunosuppression caused by M2c macrophages by Peter Probst, Huyen Dinh, Sam Lam, Valerie Wall, Darbie Whitman, Tom Graddis, Myriam Bouchlaka, Randi Simmons, Meghan Zuck, Ray Fox, Kamal Puri

    Published in Journal for ImmunoTherapy of Cancer (2021-11-01)
    Article


  3. 3

    262 Preclinical characterization of humanized anti-siglec-15 antibodies that rescue T cells from macrophage-mediated immune suppression by Lauren Loh, Peter Probst, Huyen Dinh, Sam Lam, Valerie Wall, Francisco Zapata, Darbie Whitman, Ramya Chandrasekaran, Texia Loh, Tom Graddis, Myriam Bouchlaka

    Published in Journal for ImmunoTherapy of Cancer (2021-11-01)
    Article


  4. 4

    276 Discovery and preclinical characterization of anti-LILRB2 antibodies that rescue T cells from macrophage-mediated immune suppression by Lauren Loh, Peter Probst, Huyen Dinh, Sam Lam, Valerie Wall, Francisco Zapata, Ramya Chandrasekaran, Texia Loh, Tom Graddis, Myriam Bouchlaka, Meghan Zuck, Kamal Puri

    Published in Journal for ImmunoTherapy of Cancer (2021-11-01)
    Article


  5. 5

    519 OR641 is a novel dual antagonist antibody that targets LILRB1 and LILRB2 inhibitory receptors and promotes a Th1-like immune response by Peter Probst, Kevin Green, Huyen Dinh, Francisco Zapata, Darbie Whitman, Tom Graddis, Myriam Bouchlaka, Meghan Zuck, Ray Fox, Tatyana Pisarenko, Elsa L Hay, Gajendra Naika, Jacob Heit, Kamal D Puri

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  6. 6

    494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses by Peter Probst, Kevin Green, Huyen Dinh, Francisco Zapata, Darbie Whitman, Tom Graddis, Meghan Zuck, Ray Fox, Myriam N Bouchlaka, Tatyana Pisarenko, Elsa L Hay, Gajendra Naika, Jacob Heit, Kamal D Puri

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  7. 7

    A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation. by Michelle L Scalley-Kim, Bruce W Hess, Ryan L Kelly, Anne-Rachel F Krostag, Kurt H Lustig, John S Marken, Pamela J Ovendale, Aaron R Posey, Pamela J Smolak, Janelle D L Taylor, C L Wood, David L Bienvenue, Peter Probst, Ruth A Salmon, Daniel S Allison, Teresa M Foy, Carol J Raport

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


Search Tools: